Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia
Condition(s):Acute Myeloid LeukemiaLast Updated:April 29, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid LeukemiaLast Updated:April 29, 2022Recruiting
Condition(s):Multiple SclerosisLast Updated:June 22, 2022Active, not recruiting
Condition(s):Multiple SclerosisLast Updated:July 29, 2022Recruiting
Condition(s):Leukemia, Myeloid, Acute; Leukemia, Lymphoblastic, AcuteLast Updated:June 28, 2018Unknown status
Condition(s):Multiple SclerosisLast Updated:January 13, 2022Recruiting
Condition(s):Multiple Sclerosis; Multiple Sclerosis, Relapsing-RemittingLast Updated:October 4, 2021Recruiting
Condition(s):Advanced Multiple Sclerosis; Progressive Multiple SclerosisLast Updated:June 10, 2022Recruiting
Condition(s):Acute Myeloid Leukemia Myelodysplastic SyndromesLast Updated:May 6, 2021Not yet recruiting
Condition(s):Multiple SclerosisLast Updated:May 18, 2022Recruiting
Condition(s):Multiple SclerosisLast Updated:July 20, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.